185 related articles for article (PubMed ID: 28590830)
1. Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia.
Arivazhagan J; Nandeesha H; Dorairajan LN; Sreenivasulu K
Aging Male; 2017 Jun; 20(2):115-118. PubMed ID: 28590830
[TBL] [Abstract][Full Text] [Related]
2. Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia.
Nandeesha H; Eldhose A; Dorairajan LN; Anandhi B
Andrologia; 2017 Sep; 49(7):. PubMed ID: 27658341
[TBL] [Abstract][Full Text] [Related]
3. Expression of IL-17A, E, and F and their receptors in human prostatic cancer: Comparison with benign prostatic hyperplasia.
Liu Y; Zhao X; Sun X; Li Y; Wang Z; Jiang J; Han H; Shen W; Corrigan CJ; Sun Y
Prostate; 2015 Dec; 75(16):1844-56. PubMed ID: 26356122
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of interleukin-17 and interleukin-8 in the prostatic tissue of the patients with BPH or BPH with inflammation].
Gao R; Liu QX; Zhou HL; Cao LS; Jiang T; Tang SX; Ding YL
Zhonghua Nan Ke Xue; 2017 Aug; 23(8):697-702. PubMed ID: 29726643
[TBL] [Abstract][Full Text] [Related]
6. Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options.
Janiczek M; Szylberg Ł; Antosik P; Kasperska A; Marszałek A
J Immunol Res; 2020; 2020():4910595. PubMed ID: 32537467
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
8. Elevated insulin and reduced insulin like growth factor binding protein-3/prostate specific antigen ratio with increase in prostate size in Benign Prostatic Hyperplasia.
Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V
Clin Chim Acta; 2017 Jun; 469():37-41. PubMed ID: 28300542
[TBL] [Abstract][Full Text] [Related]
9. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostate.
Handisurya A; Steiner GE; Stix U; Ecker RC; Pfaffeneder-Mantai S; Langer D; Kramer G; Memaran-Dadgar N; Marberger M
Prostate; 2001 Dec; 49(4):251-62. PubMed ID: 11746271
[TBL] [Abstract][Full Text] [Related]
12. Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes.
Norström MM; Rådestad E; Sundberg B; Mattsson J; Henningsohn L; Levitsky V; Uhlin M
Oncotarget; 2016 Apr; 7(17):23581-93. PubMed ID: 26993768
[TBL] [Abstract][Full Text] [Related]
13. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
[TBL] [Abstract][Full Text] [Related]
14. Correlation between molecular biomarkers and risk factors for the clinical progression of benign prostatic hyperplasia using tissue microarray immunostaining.
Ma D; Yang B; Zhou Z; Pan D; Zhang X
Chin Med J (Engl); 2014; 127(23):4031-5. PubMed ID: 25430444
[TBL] [Abstract][Full Text] [Related]
15. [Differences in pathological features of histological inflammation between benign prostatic hyperplasia and prostate cancer].
Yang L; Zhao K; Zhang A; Liu LR; Liu ZH; Han P; Wei Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):760-3, 768. PubMed ID: 24325107
[TBL] [Abstract][Full Text] [Related]
16. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
Bao QB; He GH; Liu GY; Zhang CG; Yang C
Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
18. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
[TBL] [Abstract][Full Text] [Related]
19. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia.
Sreenivasulu K; Nandeesha H; Dorairajan LN; Rajappa M; Vinayagam V; Cherupanakkal C
Aging Male; 2018 Jun; 21(2):138-144. PubMed ID: 29129118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
